Clinical Scorecard: A Nomogram Utilizing Standard Blood Parameters to Assess the Risk of Extended Fever in Pediatric Patients with Primary Epstein-Barr Virus Infection
At a Glance
Category
Detail
Condition
Primary Epstein-Barr Virus Infection
Key Mechanisms
Routine blood parameters including WBC, NEU, PLT, and AL are used to predict prolonged fever.
Target Population
Children hospitalized with primary EBV infection
Care Setting
Pediatric hospital setting
Key Highlights
27.4% of children experienced prolonged fever (>1 week).
Antiviral therapy was administered to all patients with prolonged fever.
The nomogram predicted prolonged fever with an AUC of 0.728.
Key predictors identified were WBC, NEU, PLT, and AL.
The study emphasizes the need for further validation through multicenter studies.
Guideline-Based Recommendations
Diagnosis
Confirm primary EBV infection through serological testing.
Management
Administer antiviral therapy as indicated for prolonged fever.
Monitoring & Follow-up
Monitor routine blood parameters to assess risk of prolonged fever.
Risks
Prolonged fever can increase distress and anxiety for patients and families.
Patient & Prescribing Data
Children aged ≤16 years with primary EBV infection.
Antiviral therapy is crucial for managing prolonged fever in this population.
Clinical Best Practices
Utilize the nomogram for early risk stratification of prolonged fever.
Incorporate routine blood parameters in the assessment of pediatric EBV infection.
